
Number of publications published per year by Dhumeaux, Daniel. (Source : PubMed)

Distribution of publications types for Dhumeaux, Daniel. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
The impact of the prevention programme of hepatitis C over more than a decade: the French experience.
J. Viral Hepat.
2009

[Centenary]
Gastroenterol. Clin. Biol.
2009;33;8-9

Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily.
J. Hepatol.
2007;46;5

The nonstructural 5A protein of hepatitis C virus genotype 1b does not contain an interferon sensitivity-determining region.
J. Infect. Dis.
2007;195;3

Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases.
Hepatology
2006;44;6


Peginterferon alpha-2b plus ribavirin for treatment of chronic hepatitis C with severe fibrosis: a multicentre randomized controlled trial comparing two doses of peginterferon alpha-2b.
J. Viral Hepat.
2006;13;12

Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users.
J. Med. Virol.
2006;78;10

Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC.
Hepatology
2006;43;5
Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients.
J. Acquir. Immune Defic. Syndr.
2006;41;2
Dynamics of hepatitis B virus resistance to lamivudine.
J. Virol.
2006;80;2
[ See timeline ] [ See all publications ]
means that Dhumeaux, Daniel has 56 papers cited a least 56 times - methodology
Department of Hepatology and Gastroenterology, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Université Paris XII, Créteil, France.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.